Cas:15220-11-8 4-Methylumbelliferyl Sulfate Potassium Salt manufacturer & supplier

We serve Chemical Name:4-Methylumbelliferyl Sulfate Potassium Salt CAS:15220-11-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Methylumbelliferyl Sulfate Potassium Salt

Chemical Name:4-Methylumbelliferyl Sulfate Potassium Salt
CAS.NO:15220-11-8
Synonyms:EINECS 239-272-2;MFCD00016970;Potassium 4-methylumbelliferyl sulfate;potassium,(4-methyl-2-oxochromen-7-yl) sulfate;4-Methylumbelliferyl sulfate potassium salt
Molecular Formula:C10H7KO6S
Molecular Weight:294.32200
HS Code:2932209090

Physical and Chemical Properties:
Melting point:287-290ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:105.02000
Exact Mass:293.96000
LogP:2.02120

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like EINECS 239-272-2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methylumbelliferyl sulfate potassium salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,potassium,(4-methyl-2-oxochromen-7-yl) sulfate Use and application,4-Methylumbelliferyl sulfate potassium salt technical grade,usp/ep/jp grade.


Related News: Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 4-Methylumbelliferyl Sulfate Potassium Salt manufacturer The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. 4-Methylumbelliferyl Sulfate Potassium Salt supplier One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. 4-Methylumbelliferyl Sulfate Potassium Salt vendor China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people. 4-Methylumbelliferyl Sulfate Potassium Salt factory China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people.